BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23382860)

  • 1. Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
    Goode EL; DeRycke M; Kalli KR; Oberg AL; Cunningham JM; Maurer MJ; Fridley BL; Armasu SM; Serie DJ; Ramar P; Goergen K; Vierkant RA; Rider DN; Sicotte H; Wang C; Winterhoff B; Phelan CM; Schildkraut JM; Weber RP; Iversen E; Berchuck A; Sutphen R; Birrer MJ; Hampras S; Preus L; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Song H; Tyrer J; Pharoah PP; Konecny G; Sellers TA; Ness RB; Sucheston LE; Odunsi K; Hartmann LC; Moysich KB; Knutson KL
    PLoS One; 2013; 8(1):e53903. PubMed ID: 23382860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
    Charbonneau B; Moysich KB; Kalli KR; Oberg AL; Vierkant RA; Fogarty ZC; Block MS; Maurer MJ; Goergen KM; Fridley BL; Cunningham JM; Rider DN; Preston C; Hartmann LC; Lawrenson K; Wang C; Tyrer J; Song H; deFazio A; Johnatty SE; Doherty JA; Phelan CM; Sellers TA; Ramirez SM; Vitonis AF; Terry KL; Van Den Berg D; Pike MC; Wu AH; Berchuck A; Gentry-Maharaj A; Ramus SJ; Diergaarde B; Shen H; Jensen A; Menkiszak J; Cybulski C; Lubiłski J; Ziogas A; Rothstein JH; McGuire V; Sieh W; Lester J; Walsh C; Vergote I; Lambrechts S; Despierre E; Garcia-Closas M; Yang H; Brinton LA; Spiewankiewicz B; Rzepecka IK; Dansonka-Mieszkowska A; Seibold P; Rudolph A; Paddock LE; Orlow I; Lundvall L; Olson SH; Hogdall CK; Schwaab I; du Bois A; Harter P; Flanagan JM; Brown R; Paul J; Ekici AB; Beckmann MW; Hein A; Eccles D; Lurie G; Hays LE; Bean YT; Pejovic T; Goodman MT; Campbell I; Fasching PA; Konecny G; Kaye SB; Heitz F; Hogdall E; Bandera EV; Chang-Claude J; Kupryjanczyk J; Wentzensen N; Lambrechts D; Karlan BY; Whittemore AS; Culver HA; Gronwald J; Levine DA; Kjaer SK; Menon U; Schildkraut JM; Pearce CL; Cramer DW; Rossing MA; Chenevix-Trench G; ; ; Pharoah PD; Gayther SA; Ness RB; Odunsi K; Sucheston LE; Knutson KL; Goode EL
    Cancer Immunol Res; 2014 Apr; 2(4):332-40. PubMed ID: 24764580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
    Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KK; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Moes-Sosnowska J; Narod SA; Nedergaard L; Nevanlinna H; Nickels S; Olson SH; Orlow I; Weber RP; Paul J; Pejovic T; Pelttari LM; Perkins B; Permuth-Wey J; Pike MC; Plisiecka-Halasa J; Poole EM; Risch HA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schmitt K; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Tangen IL; Teo SH; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; Tyrer J; van Altena AM; Vergote I; Vierkant RA; Walsh C; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Gayther SA; Ramus SJ; Sellers TA; Schildkraut JM; Phelan CM; Berchuck A; Chenevix-Trench G; Cunningham JM; Pharoah PP; Ness RB; Odunsi K; Goode EL; Moysich KB
    Oncotarget; 2016 Oct; 7(43):69097-69110. PubMed ID: 27533245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward understanding the genetics of regulatory T cells in ovarian cancer.
    Derycke MS; Charbonneau B; Preston CC; Kalli KR; Knutson KL; Rider DN; Goode EL
    Oncoimmunology; 2013 Jun; 2(6):e24535. PubMed ID: 23894717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide significant risk associations for mucinous ovarian carcinoma.
    Kelemen LE; Lawrenson K; Tyrer J; Li Q; Lee JM; Seo JH; Phelan CM; Beesley J; Chen X; Spindler TJ; Aben KK; Anton-Culver H; Antonenkova N; ; ;
    Nat Genet; 2015 Aug; 47(8):888-97. PubMed ID: 26075790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer.
    Lu L; Katsaros D; Mayne ST; Risch HA; Benedetto C; Canuto EM; Yu H
    Carcinogenesis; 2012 Nov; 33(11):2119-25. PubMed ID: 22822098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer risk associated with inherited inflammation-related variants.
    White KL; Schildkraut JM; Palmieri RT; Iversen ES; Berchuck A; Vierkant RA; Rider DN; Charbonneau B; Cicek MS; Sutphen R; Birrer MJ; Pharoah PP; Song H; Tyrer J; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Phelan CM; Cunningham JM; Fridley BL; Sellers TA; Goode EL;
    Cancer Res; 2012 Mar; 72(5):1064-9. PubMed ID: 22282663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
    Guo X; Lin W; Bao J; Cai Q; Pan X; Bai M; Yuan Y; Shi J; Sun Y; Han MR; Wang J; Liu Q; Wen W; Li B; Long J; Chen J; Zheng W
    Am J Hum Genet; 2018 May; 102(5):890-903. PubMed ID: 29727689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants associated with risk of atrial fibrillation regulate expression of PITX2, CAV1, MYOZ1, C9orf3 and FANCC.
    Martin RI; Babaei MS; Choy MK; Owens WA; Chico TJ; Keenan D; Yonan N; Koref MS; Keavney BD
    J Mol Cell Cardiol; 2015 Aug; 85():207-14. PubMed ID: 26073630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.
    Knutson KL; Maurer MJ; Preston CC; Moysich KB; Goergen K; Hawthorne KM; Cunningham JM; Odunsi K; Hartmann LC; Kalli KR; Oberg AL; Goode EL
    Cancer Immunol Immunother; 2015 Dec; 64(12):1495-504. PubMed ID: 26298430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weak sharing of genetic association signals in three lung cancer subtypes: evidence at the SNP, gene, regulation, and pathway levels.
    O'Brien TD; Jia P; Caporaso NE; Landi MT; Zhao Z
    Genome Med; 2018 Feb; 10(1):16. PubMed ID: 29486777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of
    Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk.
    Yang W; Liu H; Duan B; Xu X; Carmody D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Chen X; Wei Q
    Cancer Sci; 2019 Jun; 110(6):2022-2032. PubMed ID: 30972876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ncRNA-eQTL: a database to systematically evaluate the effects of SNPs on non-coding RNA expression across cancer types.
    Li J; Xue Y; Amin MT; Yang Y; Yang J; Zhang W; Yang W; Niu X; Zhang HY; Gong J
    Nucleic Acids Res; 2020 Jan; 48(D1):D956-D963. PubMed ID: 31410488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants at IRX4 as prostate cancer expression quantitative trait loci.
    Xu X; Hussain WM; Vijai J; Offit K; Rubin MA; Demichelis F; Klein RJ
    Eur J Hum Genet; 2014 Apr; 22(4):558-63. PubMed ID: 24022300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression quantitative trait loci (eQTL) mapping in Puerto Rican children.
    Chen W; Brehm JM; Lin J; Wang T; Forno E; Acosta-Pérez E; Boutaoui N; Canino G; Celedón JC
    PLoS One; 2015; 10(3):e0122464. PubMed ID: 25816334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
    Schildkraut JM; Goode EL; Clyde MA; Iversen ES; Moorman PG; Berchuck A; Marks JR; Lissowska J; Brinton L; Peplonska B; Cunningham JM; Vierkant RA; Rider DN; Chenevix-Trench G; Webb PM; Beesley J; Chen X; Phelan C; Sutphen R; Sellers TA; Pearce L; Wu AH; Van Den Berg D; Conti D; Elund CK; Anderson R; Goodman MT; Lurie G; Carney ME; Thompson PJ; Gayther SA; Ramus SJ; Jacobs I; Krüger Kjaer S; Hogdall E; Blaakaer J; Hogdall C; Easton DF; Song H; Pharoah PD; Whittemore AS; McGuire V; Quaye L; Anton-Culver H; Ziogas A; Terry KL; Cramer DW; Hankinson SE; Tworoger SS; Calingaert B; Chanock S; Sherman M; Garcia-Closas M;
    Cancer Res; 2009 Mar; 69(6):2349-57. PubMed ID: 19276375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
    White KL; Vierkant RA; Fogarty ZC; Charbonneau B; Block MS; Pharoah PD; Chenevix-Trench G; ; Rossing MA; Cramer DW; Pearce CL; Schildkraut JM; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean Y; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton L; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh C; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubinski J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Denberg D; Terry KL; Vitonis AF; Doherty JA; Johnatty SE; Defazio A; Song H; Tyrer J; Sellers TA; Phelan CM; Kalli KR; Cunningham JM; Fridley BL; Goode EL
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):987-92. PubMed ID: 23513043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.